- Home
- RSG vs ZTS Comparison
RSG vs ZTS Comparison
Compare RSG & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSG
- ZTS
- Stock Information
- Founded
- RSG 1996
- ZTS 1952
- Country
- RSG United States
- ZTS United States
- Employees
- RSG N/A
- ZTS N/A
- Industry
- RSG Environmental Services
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- RSG Utilities
- ZTS Health Care
- Exchange
- RSG Nasdaq
- ZTS Nasdaq
- Market Cap
- RSG 69.7B
- ZTS 66.2B
- IPO Year
- RSG 1998
- ZTS 2013
- Fundamental
- Price
- RSG $205.44
- ZTS $122.19
- Analyst Decision
- RSG Buy
- ZTS Buy
- Analyst Count
- RSG 20
- ZTS 8
- Target Price
- RSG $255.10
- ZTS $185.00
- AVG Volume (30 Days)
- RSG 1.4M
- ZTS 4.1M
- Earning Date
- RSG 10-30-2025
- ZTS 11-04-2025
- Dividend Yield
- RSG 1.21%
- ZTS 1.67%
- EPS Growth
- RSG 7.52
- ZTS 11.64
- EPS
- RSG 6.73
- ZTS 5.94
- Revenue
- RSG $16,502,000,000.00
- ZTS $9,397,000,000.00
- Revenue This Year
- RSG $5.06
- ZTS $3.84
- Revenue Next Year
- RSG $4.27
- ZTS $5.89
- P/E Ratio
- RSG $30.78
- ZTS $20.23
- Revenue Growth
- RSG 4.32
- ZTS 2.68
- 52 Week Low
- RSG $199.43
- ZTS $117.26
- 52 Week High
- RSG $258.75
- ZTS $181.85
- Technical
- Relative Strength Index (RSI)
- RSG 33.19
- ZTS 25.78
- Support Level
- RSG $201.42
- ZTS $117.26
- Resistance Level
- RSG $208.71
- ZTS $144.83
- Average True Range (ATR)
- RSG 3.83
- ZTS 2.89
- MACD
- RSG -0.41
- ZTS -2.11
- Stochastic Oscillator
- RSG 16.93
- ZTS 17.54
About RSG Republic Services Inc.
Republic Services is the second-largest integrated provider of traditional solid waste services in the United States, operating roughly 208 active landfills and 248 transfer stations. The company serves residential, commercial, and industrial end markets. It also runs sizable recycling and hazardous waste collection and disposal operations in North America.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.